Study to Evaluate an Oxaliplatin-based Chemotherapy in Patients With Resistant or Relapsing Non-Hodgkin Lymphoma.
Status:
Unknown status
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
Evaluation of the efficacy, tolerance, quality of life and cost effectiveness of the
association of Oxaliplatin, Gemcitabine, Rituximab and Dexamethasone for treatment of
patients with refractory or relapsing non-Hodgkin lymphoma.
Phase:
Phase 2
Details
Lead Sponsor:
Centre de recherche du Centre hospitalier universitaire de Sherbrooke